TCM
RETA

TimesSquare Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

TimesSquare Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$35.1M Buy
2023
Q1 		$309K Buy
2020
Q3 		– Sell
2020
Q2 		$55.5M Buy
2020
Q1 		$30.4M Buy